#NewsFlash | Inhibinol is sponsoring Club SI at Circuit of The Americas in Austin, TX, which kicks off Friday, October 22. Join us for a photo opportunity and a sampling of our new, scientifically formulated #supplement. Details at: prnewswire.com/news-releases/… #COTA #ClubSI

Check out our own Dr. Kishor M. Wasan in the latest MarketScale article for his perspective on federal initiatives that jumpstarted early #COVID19 #drugresearch + more: marketscale.com/industries/sci…

#NewFlash | Riverside University Health System Medical Center and Skymount Medical begin U.S. #clinicaltrial for #COVID19 oral therapeutics discovered using #AI Read more: skymountmed.com/2021/11/03/riv…

Our DeepDrug™ and Skymount Medical team has published a paper on "Artificial Intelligence for the discovery of novel antimicrobial agents for emerging infectious diseases" in Drug Discovery Today! Read more. lnkd.in/dJ6ijxBs #drugdiscovery #ArtificialIntelligence

Our DeepDrug and Skymount Medical team's recent paper in Drug Discovery Today has now been listed as part of the Public Health Emergency COVID-19 Initiative! Learn more here. ncbi.nlm.nih.gov/pmc/articles/P… #AI #drugdiscovery #COVID19 #PublicHealth #lsuresearch #skymountmedical #biotech

Listen to our Chief Executive Officer and Chief Medical & Scientific Officer as they discuss clinical trials, breakthroughs on COVID-19 treatments and how AI tech is disrupting drug discovery and development. youtu.be/lFsT4BUxYhc #AI #COVID19 #drugdiscovery #Pharmaceutical

An exclusive interview about how AI is supporting new therapeutic combinations, featuring our Chief Medical & Scientific Officer, has been published in the Pharmafile Autumn 2021 magazine, page 8. bit.ly/3pYuog7 Pharmafile #AI #deepdrug #COVID19 #biotech

A recent interview with our Chief Medical & Scientific Officer on the FDA's accelerated COVID-19 pill approval process and why this emergency use authorization pathway is drawing so much attention now. Learn more here. bit.ly/3noVVab MarketScale #COVID19 #publichealth

Fighting COVID-19 in partnership with LSU and the LSU-developed #ArtificialIntelligence. Read more about how DeepDrug, developed by LSU researchers, is resulting in the discovery of new treatments, faster & cheaper. bit.ly/3tKIGof #COVID19 #drugdiscovery #biotech

Results coming soon—A new #COVID19 treatment, predicted by #LSU DeepDrug #AI technology to be up to 97% effective against coronavirus, is being tested by patients in Europe and California. lsu.edu/working-for-lo… #LSUworks LSU College of the Coast & Environment LSU Engineering LSU College of Science Skymount Medical

Research never stops at LSU. Take a look at the stories in the latest LSU Research Magazine: lsu.edu/research-magaz…

We are proud of our partnership with LSU Research !

Oral medication for COVID-19 was discovered using #ArtificialIntelligence - Learn more about the LSU Research DeepDrug project and Skymount Medical's clinical trials. bit.ly/3J14tfN #COVID19 #drugdiscovery #healthcare #biotech #skymountmedical

Our Chief Medical and Scientific Officer explains how our team is facilitating accelerated drug identification, safety studies, and clinical trials in partnership with academia. Learn more. bit.ly/3sl7YHn #covid19 #drugdiscovery #biotech #Pharmaceutical #Medical #covid

Skymount Medical's Chief Medical & Scientific Officer will be a keynote speaker at the upcoming Network 4 Sustainable Nanotechnology global summit on Nanotechnology for a Healthier and Sustainable Future, on February 22. Registration details below. #AI #ArtificialIntelligence #drugdiscovery #nanotechnology

We achieved a significant milestone with the latest UK MHRA approval to conduct a clinical trial of our novel oral therapeutic for patients with mild to moderate #COVID19. Read the full announcement: bit.ly/3LRHo1u MHRAgovuk LSU Research #AI #drugdiscovery #biotech

DeepDrug - the next generation of drug discovery is here! Dr Wasan explains how to build new and safe drugs, as well as how to repurpose existing drugs, and optimize drug combinations and dosing for individual patients Network 4 Sustainable Nanotechnology Sydney Nano Sydney Uni Global Sydney Health #N4SNano

Our Chief Medical & Scientific Officer at yesterday's global summit on Nanotechnology for a Healthier and Sustainable Future, discussing our AI technology and the next generation of drug discovery. LSU Research #AI #nanotechnology #ArtificialIntelligence #drugdiscovery #COVID19

We are honored to be recognized for achievement in the Artificial Intelligence and Machine Learning Solution category with a Silver #StevieAward in the prestigious 20th Annual American Business Awards®. bit.ly/38U48zh #steviewinner2022 LSU News #AI The Stevie® Awards